Shari L. Ohringer

Statistics

Publications

Citations

206

H-Index

Active since

1987

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Shari L. Ohringer is an author at Bristol-Myers Squibb (United States) specializing in life sciences, β-lactam antibiotics, and antibiotic resistance mechanisms.

Publications per year

1987–1996

Publications

Substitution of lysine at position 104 or 240 of TEM-1pTZ18R .beta.-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam

Judith A. Sowek, Susan B. Singer, Shari L. Ohringer et al. · Biochemistry · 1991 · 96 citations

Life Sciences, Biochemistry, Microbiology +17

Structure of a Retro-binding Peptide Inhibitor Complexed with Human α-Thrombin

Lydia Taberno, ChiehYing Y. Chang, Shari L. Ohringer et al. · Journal of Molecular Biology · 1995 · 39 citations

Medicine, Biochemistry, Medicinal Chemistry +14

Crystallographic determination of the structures of human α‐thrombin complexed with BMS‐186282 and BMS‐189090

Mary F. Malley, John S. Sack, Lydia Tabernero et al. · Protein Science · 1996 · 35 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coli

Karen Bush, Sandra Smith, Shari L. Ohringer et al. · Antimicrobial Agents and Chemotherapy · 1987 · 20 citations · Full text

Life Sciences, Molecular Biology, Antimicrobial Resistance +13

Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase

Karen Bush, Robert K. Flamm, Shari L. Ohringer et al. · Antimicrobial Agents and Chemotherapy · 1991 · 16 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +16

1–5 of 5